Tyrosine kinase nerve growth factor receptor switches from prosurvival to proapoptotic activity via Abeta-mediated

C Matrone1, R Marolda, S Ciafrè

  • 1Institute of Neurobiology and Molecular Medicine, National Research Council, via del Fosso del Fiorano 64, 00143 Rome, Italy. c.matrone@inmm.cnr.it

Insights

Increased amyloid-beta (Abeta) production triggers abnormal tyrosine kinase receptor A (TrkA) phosphorylation, activating a death pathway in neurons. Inhibiting this pathway protects against neuronal death, suggesting a novel Alzheimer's disease mechanism.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cellular Signaling

Background:

  • Amyloid-beta (Abeta) production is implicated in Alzheimer's disease pathogenesis.
  • Nerve Growth Factor (NGF) signaling is crucial for neuronal survival and function.
  • Dysregulation of cellular signaling pathways can lead to neurodegeneration.

Purpose of the Study:

  • To investigate the role of NGF signal failure and Abeta production in hippocampal neuron death.
  • To elucidate the signaling pathway linking Abeta production to neuronal apoptosis.
  • To identify potential therapeutic targets for Alzheimer's disease by understanding this mechanism.

Main Methods:

  • Investigated Abeta production and tyrosine kinase receptor A (TrkA) phosphorylation in hippocampal neurons.
  • Analyzed the activation of the phospholipase C gamma (PLCgamma) pathway.
  • Utilized pharmacologic inhibition and receptor silencing (TrkA, p75) to assess neuroprotection.
  • Performed coimmunoprecipitation to study protein interactions (TrkA, p75, Abeta, PS1).

Main Results:

  • Increased Abeta production due to NGF signal failure induced abnormal TrkA phosphorylation.
  • This phosphorylation activated the PLCgamma pathway, leading to neuronal death.
  • Inhibition of TrkA phosphorylation and silencing of TrkA/p75 receptors prevented PLCgamma activation and protected neurons.
  • TrkA, p75, Abeta, and PS1 were found to coimmunoprecipitate, indicating direct interplay.

Conclusions:

  • A cellular mechanism exists where a trophic signaling system can switch to a death-inducing pathway.
  • This pathway involves Abeta production, TrkA phosphorylation, PLCgamma activation, and p75 processing.
  • Targeting TrkA phosphorylation and TrkA/p75 receptors offers a potential therapeutic strategy for Alzheimer's disease.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...